Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by mmaltaison Jan 21, 2019 3:33pm

184 Views

Post# 29261145

Short position on PLI january 15th for the TSX only

Short Positions for PLI

Symbol	Report Date	Volume	Change	Shares Issued	% Float
T : PLI	2019-01-15	6,511,630	-8,411,644	720,368,286	0.90
T : PLI	2018-12-31	14,923,274	7,075,180	718,126,512	2.08
T : PLI	2018-12-15	7,848,094	39,587	718,126,512	1.09
T : PLI	2018-11-30	7,808,507	-1,554,806	718,126,512	1.09
T : PLI	2018-11-15	9,363,313	1,254,630	718,126,512	1.30